0000899243-17-019214.txt : 20170727 0000899243-17-019214.hdr.sgml : 20170727 20170727182945 ACCESSION NUMBER: 0000899243-17-019214 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170725 FILED AS OF DATE: 20170727 DATE AS OF CHANGE: 20170727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Winder Caleb Maxfield CENTRAL INDEX KEY: 0001709840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38130 FILM NUMBER: 17987397 MAIL ADDRESS: STREET 1: C/O AILERON THERAPEUTICS, INC. STREET 2: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AILERON THERAPEUTICS INC CENTRAL INDEX KEY: 0001420565 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-995-0900 MAIL ADDRESS: STREET 1: 281 ALBANY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-07-25 0 0001420565 AILERON THERAPEUTICS INC ALRN 0001709840 Winder Caleb Maxfield C/O AILERON THERAPEUTICS, INC. 281 ALBANY STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 13.00 2017-07-25 4 A 0 20000 0.00 A 2027-07-24 Common Stock 20000 20000 D This option was granted on July 25, 2017. The shares underlying the option are scheduled to vest in equal annual installments over three years from July 25, 2017. /s/ Kira A. Nelson, attorney-in-fact for Caleb Maxfield Winder 2017-07-27